Tempus AI's Data Arm Surges with 69.5% Insights Growth and $1.1B+ Contracts

AI-driven expansion fuels strong revenue outlook and customer retention gains for Tempus' data and applications business.

Apr. 10, 2026 at 8:15am

Got story updates? Submit your updates here. ›

A highly detailed, glowing 3D macro illustration of a complex neural network diagram in shades of cyan and magenta, conceptually representing the advanced AI models powering Tempus' data and analytics solutions.Tempus' AI-driven data and analytics solutions are fueling the company's robust growth and expanding its reach across the global healthcare industry.NYC Today

Tempus AI's Data and Applications business delivered robust momentum in 2025, with Insights revenue growing 69.5% and total contract value exceeding $1.1 billion. The company's investment in artificial intelligence, particularly large-scale foundation models trained on proprietary datasets, is expected to drive increasingly advanced insights across oncology and other medical fields, strengthening both the licensing and application businesses. Tempus also added 30 new customers in Q4 2025, including leading institutions globally, while deepening engagement with existing customers and achieving 126% net revenue retention.

Why it matters

Tempus' data and applications arm is a key driver of the company's growth, as it leverages AI and proprietary datasets to deliver advanced insights that are in high demand across the healthcare industry. The strong performance and future outlook for this business segment underscore Tempus' position as a leader in the rapidly evolving field of medical data and analytics.

The details

Tempus' Data and Applications business delivered 69.5% growth in Insights revenue in Q4 2025, excluding the prior-year impact of the AstraZeneca warrant. Total contract value exceeded $1.1 billion, while net revenue retention reached 126%, indicating that existing customers are expanding their use of Tempus' services over time. Management expects approximately $1.59 billion in 2026 revenues, implying 25% growth, as the company continues to invest in AI and expand into new data types such as radiology, cardiology, and neuropsychology.

  • Tempus reported Q4 2025 results in early 2026.
  • The company expects to generate around $1.59 billion in revenues in 2026.

The players

Tempus

A healthcare technology company that specializes in data and analytics solutions for the medical industry.

NYU Langone Health

A leading academic medical center in the United States that became a new Tempus customer in Q4 2025.

AZ Delta

A healthcare institution in Belgium that became a new Tempus customer in Q4 2025.

Human Genome & Stem Cell Research Center

A research center in Brazil that became a new Tempus customer in Q4 2025.

Tyrolpath

One of Austria's largest pathology laboratories that became a new Tempus customer in Q4 2025.

Got photos? Submit your photos here. ›

The takeaway

Tempus' strong performance in its Data and Applications business, driven by AI-powered insights and growing customer adoption, positions the company as a leader in the rapidly evolving healthcare data and analytics market. The company's ability to deliver advanced, customized solutions that address the needs of a diverse range of medical institutions globally is a key competitive advantage.